Matches in Wikidata for { <http://www.wikidata.org/entity/Q92741444> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q92741444 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92741444 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92741444 description "scientific article published on 01 April 2019" @default.
- Q92741444 description "wetenschappelijk artikel" @default.
- Q92741444 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q92741444 name "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 name "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 type Item @default.
- Q92741444 label "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 label "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 prefLabel "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 prefLabel "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 P1433 Q92741444-BD230A1A-D11A-4006-8E04-8AEC4BA55F67 @default.
- Q92741444 P1476 Q92741444-8DBDFCF2-5743-4A62-9C9F-B908DF40335C @default.
- Q92741444 P2093 Q92741444-06B8A4D1-6040-4EEE-9F83-455C57B48BED @default.
- Q92741444 P2093 Q92741444-09E8A411-26CD-4801-BC45-9FE8291E8A8D @default.
- Q92741444 P2093 Q92741444-112A43C9-054E-418C-8CF4-F3995882B7D7 @default.
- Q92741444 P2093 Q92741444-229A29CD-E3A0-486D-A8A2-9D72BFB27EDC @default.
- Q92741444 P2093 Q92741444-2DC56C4A-8530-4181-9762-03A7DBF45381 @default.
- Q92741444 P2093 Q92741444-3ADE7CC1-EB29-435E-989E-760E0272BF27 @default.
- Q92741444 P2093 Q92741444-3B489852-CB99-4A67-B93B-34C495803B21 @default.
- Q92741444 P2093 Q92741444-5D9AA49B-6425-46B8-9462-B2E4AAE553E9 @default.
- Q92741444 P2093 Q92741444-63B01EEA-0B30-4A8D-B626-FAFE26C862D3 @default.
- Q92741444 P2093 Q92741444-85DE883D-E758-44BC-9B1E-394E363ADB4D @default.
- Q92741444 P2093 Q92741444-9428949E-A1E9-43B5-A9BB-1A68E9E99610 @default.
- Q92741444 P2093 Q92741444-B88EEAED-3A9B-48C9-BC90-DC9D3B3CF690 @default.
- Q92741444 P275 Q92741444-6565a31f-b0a4-48a3-9214-e0c99f93679c @default.
- Q92741444 P304 Q92741444-B9D94660-0DC4-4FB3-BC09-53A91BA1BEC2 @default.
- Q92741444 P31 Q92741444-B4C3040F-2648-42BC-90C8-2FDCF0D43B2E @default.
- Q92741444 P356 Q92741444-D499F022-40A0-499D-9DC4-0DFF8E9F865D @default.
- Q92741444 P433 Q92741444-687AE60F-D9BD-488B-A039-00109C5E7AC4 @default.
- Q92741444 P478 Q92741444-5F2D95CD-56E4-45F6-B53E-86608BE541AA @default.
- Q92741444 P50 Q92741444-48F7E02E-D639-43D4-AC1D-944CA8D009D7 @default.
- Q92741444 P50 Q92741444-FA622337-9CD8-47D1-8258-A157A2F7FC2B @default.
- Q92741444 P577 Q92741444-515B1F9F-34F3-4ABC-AD4A-3A19AFB8A6F4 @default.
- Q92741444 P6216 Q92741444-61978fb9-0546-4f3d-9828-a52c91ca8585 @default.
- Q92741444 P698 Q92741444-29B1BCF3-77FE-406C-B4DA-DDB90E1B10BC @default.
- Q92741444 P921 Q92741444-15715EA7-5A7B-4A05-BFAA-19A192F36D19 @default.
- Q92741444 P356 REUMATISMO.2019.1154 @default.
- Q92741444 P698 30932440 @default.
- Q92741444 P1433 Q26867029 @default.
- Q92741444 P1476 "Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)" @default.
- Q92741444 P2093 "A Marsico" @default.
- Q92741444 P2093 "A Semeraro" @default.
- Q92741444 P2093 "C Zuccaro" @default.
- Q92741444 P2093 "D Mazzotta" @default.
- Q92741444 P2093 "F D'Onofrio" @default.
- Q92741444 P2093 "F P Cantatore" @default.
- Q92741444 P2093 "G Carlino" @default.
- Q92741444 P2093 "L Quarta" @default.
- Q92741444 P2093 "L Santo" @default.
- Q92741444 P2093 "M Muratore" @default.
- Q92741444 P2093 "P C Falappone" @default.
- Q92741444 P2093 "R Bucci" @default.
- Q92741444 P275 Q34179348 @default.
- Q92741444 P304 "24-30" @default.
- Q92741444 P31 Q13442814 @default.
- Q92741444 P356 "10.4081/REUMATISMO.2019.1154" @default.
- Q92741444 P433 "1" @default.
- Q92741444 P478 "71" @default.
- Q92741444 P50 Q38544900 @default.
- Q92741444 P50 Q90661358 @default.
- Q92741444 P577 "2019-04-01T00:00:00Z" @default.
- Q92741444 P6216 Q50423863 @default.
- Q92741444 P698 "30932440" @default.
- Q92741444 P921 Q187255 @default.